Search Within

Gabriela Chiosis

Formats
  1. Journal Article (169)
  2. Meeting Abstract (94)
  3. Review (10)
  4. Book Section (3)
  5. Editorial (2)
  6. Correspondence (1)
Groups
  1. Center for Hematologic Malignancies (279)
  2. GSK Faculty (279)
  3. Hematologic Malignancies Research (279)
  4. Molecular Pharmacology and Chemistry Program Faculty (279)
  5. Sloan Kettering Institute Faculty (279)
  6. Sloan Kettering Institute Postdocs (136)

More Groups

People
  1. Tony Taldone (88)
  2. Anna Rodina Balingcongan (55)
  3. Maria Caldas Lopes- Vazquez (33)
  4. Neal Rosen (28)
  5. Hardik Patel (26)
  6. Sahil Sharma (26)

More People

Years
  1. 2025 (4)
  2. 2024 (9)
  3. 2023 (11)
  4. 2022 (5)
  5. 2021 (7)
  6. 2020 (12)

More Years

Publications
  1. Cancer Research (33)
  2. Blood (30)
  3. Abstracts of Papers of the American Chemical Society (8)
  4. Journal of Medicinal Chemistry (8)
  5. Nature Communications (8)
  6. Bioorganic & Medicinal Chemistry Letters (7)

More Publications

Publishers
  1. American Association for Cancer Research (45)
  2. American Society of Hematology (30)
  3. Nature Publishing Group (25)
  4. American Chemical Society (24)
  5. Pergamon-Elsevier Science Ltd (16)
  6. Elsevier Inc. (15)

More Publishers

Results (279)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Hsp90 inhibitor PU-H71, a multimodal inhibitor of malignancy, induces complete responses in triple-negative breast cancer models
    Journal Article

    Caldas-Lopes, E.; Cerchietti, L.; Ahn, J. H.; Clement, C. C.; Robles, A. I.; Rodina, A.; Moulick, K.; Taldone, T.; Gozman, A.; Guo, Y.; more...
    Proceedings of the National Academy of Sciences of the United States of America (2009)

    Fulltext@MSK | Save
  • Targeting heat shock protein 90 with non-quinone inhibitors: A novel chemotherapeutic approach in human hepatocellular carcinoma
    Journal Article

    Breinig, M.; Caldas-Lopes, E.; Goeppert, B.; Malz, M.; Rieker, R.; Bergmann, F.; Schirmacher, P.; Mayer, M.; Chiosis, G.; Kern, M. A.
    Hepatology (2009)

    Fulltext@MSK | Save
  • In vivo antitumor efficacy of purine-scaffold HsP90 inhibitors in basal-like breast cancer (BLBC)
    Meeting Abstract

    Lopes, E. C.; Cerchietti, L.; Robles, A.; Varticovski, L.; Melnick, A.; Chiosis, G.
    Cancer Research (2008)

    Fulltext@MSK | Save
  • Hsp90 inhibitors: The journey from a designed lead to a clinical candidate
    Meeting Abstract

    Chiosis, G.
    Abstracts of Papers of the American Chemical Society (2008)

    Fulltext@MSK | Save
  • Synergy of the purine-scaffold hsp90 inhibitor, PU-H71, with doxorubicin and etoposide in non-hodgkin's lymphoma cell lines
    Meeting Abstract

    Robles, A.; Caldas-Lopes, E.; Chiosis, G.; Varticovski, L.
    Annals of Oncology (2008)

    Fulltext@MSK | Save
  • Antitumor efficacy of the purine-scaffold Hsp90 inhibitor PU-H71 in diffuse large-B cell lymphoma
    Meeting Abstract

    Lopes, E. C.; Cerchietti, L.; Yang, S. N.; Melnick, A.; Chiosis, G.
    Blood (2008)

    Fulltext@MSK | Save
  • Purine-scaffold HSP90 inhibitors: The journey from a designed lead to a clinical candidate
    Meeting Abstract

    Chiosis, G.
    Annals of Oncology (2008)

    Fulltext@MSK | Save
  • MEDI 188-Hsp90 inhibitors: The journey from a designed lead to a clinical candidate
    Meeting Abstract

    Chiosis, G.
    Abstracts of Papers of the American Chemical Society (2008)

    Fulltext@MSK | Save
  • Targeting the molecular chaperone Hsp90 as a novel chemotherapeutic strategy for hepatocellular carcinoma (HCC)
    Meeting Abstract

    Breinig, M.; Goeppert, B.; Malz, M.; Schir-Macher, P.; Chiosis, G.; Kern, M. A.
    Hepatology (2008)

    Fulltext@MSK | Save
  • Targeting the molecular chaperone Hsp90 as a novel chemotherapeutic strategy for hepatocellular carcinoma (HCC)
    Meeting Abstract

    Breinig, M.; Goeppert, B.; Malz, M.; Schirmacher, P.; Chiosis, G.; Kern, M. A.
    Hepatology (2008)

    Fulltext@MSK | Save